Variational AI will participate in the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), one of North America’s leading gatherings for healthcare investors and emerging life sciences companies.
Meet with Variational AI
Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will attend the conference to meet with investors and discuss the company’s approach to applying generative AI to drug discovery.
If you are attending the conference and would like to learn more about Variational AI’s work in generative molecular design and AI-driven drug discovery, we welcome the opportunity to connect.
About the event
Held annually in Toronto, Canada, the Bloom Burton Healthcare Investor Conference brings together publicly traded and private healthcare companies alongside institutional investors from Canada, the United States, and internationally.
The conference provides a forum for companies to share updates, explore partnerships, and engage in one-on-one meetings with investors interested in the latest developments in healthcare innovation.
With participants from across biotechnology, therapeutics, and healthcare technology, BBHIC has become a key venue for discussing trends shaping the future of the healthcare sector and the investment landscape supporting it.